We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 May 21
The approval is based on data from the Phase 3 clinical trial, which enrolled 2,260 adolescents aged 12…
06 May 21
The EC approval represents Tecentriq’s fourth indication in metastatic NSCLC and fifth indication in lung cancer overall in…
05 May 21
Pfizer said that its first-quarter 2021 operational growth was primarily driven by the Pfizer-BioNTech Covid-19 vaccine, BNT162b2, which…
05 May 21
Kuur’s NKT cell platform technology will help Athenex to expand its cell therapy development capabilities
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
04 May 21
The transaction will enable Roivant Sciences to become a public entity and is expected to be listed on…
04 May 21
The investigational therapy has been designed to address the genetic deficiency of the naturally occurring enzyme which is…
03 May 21
Farxiga is said to have reduced the risk of the composite of worsening of renal function, end-stage kidney…
03 May 21
The company filed its sBLA application based on the Phase 3 CheckMate -274 trial, in which Opdivo increased…
30 Apr 21
Ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged two years and…
29 Apr 21
The acquisition follows Pfizer’s initial equity investment in Amplyx, as part of the antifungal therapies developer's Series C…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates